These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31817608)

  • 1. The Impact of p53 on Aristolochic Acid I-Induced Gene Expression In Vivo.
    Sborchia M; Keun HC; Phillips DH; Arlt VM
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro.
    Sborchia M; De Prez EG; Antoine MH; Bienfait L; Indra R; Valbuena G; Phillips DH; Nortier JL; Stiborová M; Keun HC; Arlt VM
    Arch Toxicol; 2019 Nov; 93(11):3345-3366. PubMed ID: 31602497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiles modulated by the human carcinogen aristolochic acid I in human cancer cells and their dependence on TP53.
    Simões ML; Hockley SL; Schwerdtle T; Gamboa da Costa G; Schmeiser HH; Phillips DH; Arlt VM
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):86-98. PubMed ID: 18639569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice.
    Arlt VM; Zuo J; Trenz K; Roufosse CA; Lord GM; Nortier JL; Schmeiser HH; Hollstein M; Phillips DH
    Int J Cancer; 2011 Jan; 128(1):21-32. PubMed ID: 20232387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models.
    Bastek H; Zubel T; Stemmer K; Mangerich A; Beneke S; Dietrich DR
    Toxicology; 2019 May; 420():29-38. PubMed ID: 30940547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.
    Bieler CA; Stiborova M; Wiessler M; Cosyns JP; van Ypersele de Strihou C; Schmeiser HH
    Carcinogenesis; 1997 May; 18(5):1063-7. PubMed ID: 9163697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal chymase-dependent pathway for angiotensin II formation mediated acute kidney injury in a mouse model of aristolochic acid I-induced acute nephropathy.
    Hsieh WY; Chang TH; Chang HF; Chuang WH; Lu LC; Yang CW; Lin CS; Chang CC
    PLoS One; 2019; 14(1):e0210656. PubMed ID: 30633770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney.
    Xing G; Qi X; Chen M; Wu Y; Yao J; Gong L; Nohmi T; Luan Y; Ren J
    Mutat Res; 2012 Mar; 743(1-2):52-8. PubMed ID: 22245565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalin Protects Mice from Aristolochic Acid I-Induced Kidney Injury by Induction of CYP1A through the Aromatic Hydrocarbon Receptor.
    Wang K; Feng C; Li C; Yao J; Xie X; Gong L; Luan Y; Xing G; Zhu X; Qi X; Ren J
    Int J Mol Sci; 2015 Jul; 16(7):16454-68. PubMed ID: 26204831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aristolochic acid I-induced DNA damage and cell cycle arrest in renal tubular epithelial cells in vitro.
    Li Y; Liu Z; Guo X; Shu J; Chen Z; Li L
    Arch Toxicol; 2006 Aug; 80(8):524-32. PubMed ID: 16609888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mutational Features of Aristolochic Acid-Induced Mouse and Human Liver Cancers.
    Lu ZN; Luo Q; Zhao LN; Shi Y; Wang N; Wang L; Han ZG
    Hepatology; 2020 Mar; 71(3):929-942. PubMed ID: 31692012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I.
    Xue X; Gong LK; Maeda K; Luan Y; Qi XM; Sugiyama Y; Ren J
    Mol Pharm; 2011 Dec; 8(6):2183-92. PubMed ID: 21980933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aristolochic acid I interferes with the expression of BLCAP tumor suppressor gene in human cells.
    Huang YT; Wu TS; Lu CC; Yu FY; Liu BH
    Toxicol Lett; 2018 Jul; 291():129-137. PubMed ID: 29655784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid.
    Hollstein M; Moriya M; Grollman AP; Olivier M
    Mutat Res; 2013; 753(1):41-49. PubMed ID: 23422071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytochromes P450 in metabolism of carcinogenic aristolochic acid I: evidence of their contribution to aristolochic acid I detoxication and activation in rat liver.
    Stiborova M; Mares J; Levova K; Pavlickova J; Barta F; Hodek P; Frei E; Schmeiser HH
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():121-30. PubMed ID: 22167220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ergosta-4,6,8(14),22-tetraen-3-one isolated from Polyporus umbellatus prevents early renal injury in aristolochic acid-induced nephropathy rats.
    Zhao YY; Zhang L; Mao JR; Cheng XH; Lin RC; Zhang Y; Sun WJ
    J Pharm Pharmacol; 2011 Dec; 63(12):1581-6. PubMed ID: 22060289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteinyl leukotrienes synthesis is involved in aristolochic acid I-induced apoptosis in renal proximal tubular epithelial cells.
    Yang H; Dou Y; Zheng X; Tan Y; Cheng J; Li L; Du Y; Zhu D; Lou Y
    Toxicology; 2011 Sep; 287(1-3):38-45. PubMed ID: 21658425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of renal NQO1 activity by dicoumarol suppresses nitroreduction of aristolochic acid I and attenuates its nephrotoxicity.
    Chen M; Gong L; Qi X; Xing G; Luan Y; Wu Y; Xiao Y; Yao J; Li Y; Xue X; Pan G; Ren J
    Toxicol Sci; 2011 Aug; 122(2):288-96. PubMed ID: 21613233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase.
    Stiborová M; Frei E; Sopko B; Sopková K; Marková V; Lanková M; Kumstýrová T; Wiessler M; Schmeiser HH
    Carcinogenesis; 2003 Oct; 24(10):1695-703. PubMed ID: 12869422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR.
    Arlt VM; Schmeiser HH; Pfeifer GP
    Carcinogenesis; 2001 Jan; 22(1):133-40. PubMed ID: 11159751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.